Seed funding start-ups in Emerging Technologies: perspectives on cell therapeutics

In Partnering & Investment, Regenerative Medicine by Matt TurnerLeave a Comment

seed funding, stem cells, cell therapy, regenerative medicine, alain vertesSyndicate Innovation Venturing:

“Bringing together actors from complementary economic sectors in a ‘non-zero sum game' partnership to conduct seed funding in technology areas with blockbuster potential”

Alain Vertes, General Managing Partner & Co-founder at Park BioVentures (and previous Global Alliance Director at Roche) delivered a presentation at the 2012 World Stem Cells & Regenerative Medicine Congress to discuss strategic biotech innovation venturing and escaping the valley of death through seed funding.

Alain delved into how to secure the funds and establishing the collaborations to start up successfully for a cell therapy and understanding the basic model of syndicate innovation venturing.

JUST RELEASED: You can download Alain Vertes presentation in PDF format today.

There are more presentations from this years World Stem Cells & Regenerative Medicine Congress available for download and plenty more set to be released in future posts.

Why not read Astrazenca's presentation on How to use stem cells for functional analysis and target discovery

Leave a Comment

Current ye@r *